Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline
Roger E. G. Schutgens(Utrecht University), Eveline P. Mauser‐Bunschoten(University Medical Center Utrecht), A. Tuinenburg(Altrecht GGZ), Siyrous Hoseyni Guyomi(University Medical Center Utrecht), G. Roosendaal(De Forensische Zorgspecialisten)
Cited by 73
Related Papers
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
|Blood|2017|300
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
|Haemophilia|2011|244
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
|The Lancet Haematology|2021|237